![]() |
|||
|
•
Overview The technology that measures tissue blood perfusion, which is based on the principles of thermal diffusion, was originally conceived at the Massachusetts Institute of Technology (MIT) by Hemedex's co-founder and Chairman, H. Frederick Bowman, Ph.D. The technology paradigm for the Hemedex perfusion measuring system, called the Bowman Perfusion Monitor System, consists of a minimally invasive microprobe (Click HERE to view), appropriate insertion hardware for facilitating placement of the probe into the target tissue, an umbilical cable to connect the probe to the monitor, and a microprocessor-controlled, electronic monitor to collect, store, and display the perfusion data. The insertion hardware will be packaged together in the form of a kit, and will include devices necessary to secure the probe in place, and minimize the risk of infection. This platform technology will greatly benefit numerous clinical situations where specific, quantitative knowledge of blood flow and oxygen delivery, in real time, is crucial. What is
Perfusion? Why is it
important? How is perfusion
otherwise measured? LDF can provide
continuous monitoring; however, the signal depends on a number of factors
such as hematocrit, red blood cell velocity, vascular geometry, and tissue
optical properties, which vary according to tissue type. Thus, it is not
currently possible to apply the LDF calibration and measurements from
one tissue type to another tissue type. Further, it is unlikely that LDF
units can be converted to absolute blood flow in all tissues. LDF may
be useful, however, in validating perfusion variation for comparison to
other measurement techniques. Thus, there is no other technique available
that can monitor tissue perfusion continuously and in real time. [ TOP ] |
|
|
|
|||